FIELD: medicine.
SUBSTANCE: transdermal or transmucosal composition for treatment of testicular failure due to testicles abnormalities, Klinefelter syndrome, congenital abnormalities of sex chromosomes X and Y, retained testis, hemochromatosis, high levels of iron in blood, testicular trauma, previous hernia surgery, cancer treatment, normal ageing; secondary hypogonadism due to pituitary defects associated with brain that regulates hormone secretion, weakened testicular function, inflammatory diseases and application of drugs for treatment of psychiatric disorders and gastroesophageal reflux disease, ageing; and infertility, fatigue, loss of energy, depressed mood, regression of secondary sexual characteristics of male subjects, contains: 2 wt % of testosterone, C2-C4 alkanol, approx. 20 wt % of polyalcohol and monoalkyl ester of diethylene glycol.
EFFECT: composition has a good skin tolerability.
34 cl, 13 dwg, 10 tbl, 8 ex
